Bulletin
Investor Alert

New York Markets Open in:

Sanofi ADR

NAS: SNY

GO
/marketstate/country/us

Before the Bell

SNY
/zigman2/quotes/201967021/composite

$

46.14

Change

+0.08 +0.17%

Volume

Volume 712

Dec 8, 2023, 5:52 a.m.

Quotes are delayed by 20 min

/zigman2/quotes/201967021/composite

Previous close

$ 46.06

$ 46.06

Change

+0.08 +0.17%

Day low

Day high

$45.36

$46.20

Open
Open: 45.77

52 week low

52 week high

$42.63

$57.82

Open

Market cap

$116.79B

Average volume

2.27M

P/E ratio

12.92

Rev. per Employee

$494,994

EPS

3.57

Dividend

N/A

Div yield

2.99%

Ex dividend date

5/26/22

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/sny

MarketWatch News on SNY

  1. A Golden Age of Vaccines Is Here. What It Means for You.

    3:20 p.m. Nov. 21, 2023

    - Neal Templin

  2. Teva shares climb as third-quarter sales top estimates

    8:46 a.m. Nov. 8, 2023

    - Eleanor Laise

  3. Pharma Stocks Are Bleeding. 2 Look Like Bargains.

    10:51 a.m. Nov. 6, 2023

    - Josh Nathan-Kazis

  4. Moderna Reports Big Loss in Post-Pandemic Reset

    6:30 a.m. Nov. 2, 2023

    - Josh Nathan-Kazis

  5. GSK Raises Guidance on Strong Sales of Arexvy Vaccine

    10:55 a.m. Nov. 1, 2023

    - Josh Nathan-Kazis

  6. Drug Stocks Keep Tanking on Earnings. Brace for More.

    11:08 a.m. Oct. 30, 2023

    - Josh Nathan-Kazis

  7. MeiraGTx shares jump as Sanofi invests in gene therapy

    8:28 a.m. Oct. 30, 2023

    - Eleanor Laise

  8. Sanofi to Spin Out Consumer Health Division

    11:37 a.m. Oct. 27, 2023

    - Josh Nathan-Kazis

  9. Companies Push Forward With RSV Vaccine Amid Shortages

    12:02 p.m. Oct. 25, 2023

    - Josh Nathan-Kazis

  10. Stocks Poised to Open Higher

    6:35 p.m. Oct. 22, 2023

    - Janet H. Cho

  11. Big Tech Stocks, Boeing Earnings, GDP, and More

    2:00 p.m. Oct. 22, 2023

    - Nicholas Jasinski

  12. Moderna Says Flu-Covid Vaccine Succeeds in Early-Stage Trial

    10:34 a.m. Oct. 4, 2023

    - Josh Nathan-Kazis

  13. Pfizer maternal RSV vaccine recommended by CDC

    5:24 p.m. Sept. 22, 2023

    - Eleanor Laise

  14. Pfizer maternal RSV vaccine recommended by CDC advisors

    2:58 p.m. Sept. 22, 2023

    - Eleanor Laise

  15. Loading more headlines...
/news/nonmarketwatch/company/us/sny

Other News on SNY

No News currently available for SNY

/news/pressrelease/company/us/sny

Press Releases on SNY

No News currently available for SNY

Rates »

Link to MarketWatch's Slice.